Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD
- PMID: 29584449
- DOI: 10.1080/10408398.2018.1458021
Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD
Abstract
Objective: We systematically reviewed available randomized clinical trials (RCTs) to elucidate the overall effects of synbiotic supplementation in patients with nonalcoholic fatty liver disease (NAFLD). Methods: PubMed, Scopus, ISI Web of science and Google Scholar were searched up to December, 2017. All RCTs using synbiotic supplements to treat NAFLD included in this systematic review and meta-analysis. Mean Difference (MD) was pooled using a random-effects model. Results: Eleven eligible databases from seven RCTs were identified for the present meta-analysis. Our results showed that synbiotic supplementation can decrease body weight, fasting blood sugar, insulin, low density lipoprotein cholesterol, total cholesterol, triglyceride, high-sensitivity C-reactive protein, tumor necrosis factor alpha, alanine transaminase and aspartate transaminase levels among patients with NAFLD. In contrast, synbiotic did not have favorable effects on body mass index (BMI), waist circumference, homeostasis model assessment for insulin resistance (HOMA-IR), and high density lipoprotein cholesterol (HDL) levels compared with the placebo group. Conclusion: The current study revealed that synbiotic supplementation has favorable effect on inflammatory factors, liver enzymes and some anthropometric indices, lipid profiles and glucose homeostasis parameters in patients with NAFLD.
Keywords: NAFLD; Synbiotic; inflammation; insulin.
Similar articles
-
The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2019 Jun;31(6):703-715. doi: 10.1097/MEG.0000000000001371. Eur J Gastroenterol Hepatol. 2019. PMID: 31009401
-
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.Dig Dis Sci. 2019 Dec;64(12):3402-3412. doi: 10.1007/s10620-019-05699-z. Epub 2019 Jun 15. Dig Dis Sci. 2019. PMID: 31203554 Review.
-
Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials.Clin Nutr. 2021 Jul;40(7):4662-4673. doi: 10.1016/j.clnu.2021.05.027. Epub 2021 Jun 8. Clin Nutr. 2021. PMID: 34237694
-
Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.Nutr Clin Pract. 2013 Feb;28(1):101-11. doi: 10.1177/0884533612454884. Epub 2012 Oct 5. Nutr Clin Pract. 2013. PMID: 23042833
-
Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials.Phytother Res. 2018 Oct;32(10):1876-1884. doi: 10.1002/ptr.6130. Epub 2018 Jun 27. Phytother Res. 2018. PMID: 29947156 Review.
Cited by
-
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.Curr Obes Rep. 2023 Sep;12(3):191-206. doi: 10.1007/s13679-023-00519-y. Epub 2023 Jul 5. Curr Obes Rep. 2023. PMID: 37407724 Free PMC article. Review.
-
The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses.Front Endocrinol (Lausanne). 2024 Mar 20;15:1277921. doi: 10.3389/fendo.2024.1277921. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38572479 Free PMC article.
-
Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.Front Nutr. 2023 Feb 14;10:1014010. doi: 10.3389/fnut.2023.1014010. eCollection 2023. Front Nutr. 2023. PMID: 36866059 Free PMC article.
-
Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.Can Liver J. 2024 May 8;7(2):299-315. doi: 10.3138/canlivj-2023-0022. eCollection 2024 May. Can Liver J. 2024. PMID: 38746865 Free PMC article.
-
The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.Front Nutr. 2022 Oct 25;9:1024678. doi: 10.3389/fnut.2022.1024678. eCollection 2022. Front Nutr. 2022. PMID: 36386939 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials